NO985341L - Formulering omfattende mikropartikler for inhalering - Google Patents

Formulering omfattende mikropartikler for inhalering

Info

Publication number
NO985341L
NO985341L NO985341A NO985341A NO985341L NO 985341 L NO985341 L NO 985341L NO 985341 A NO985341 A NO 985341A NO 985341 A NO985341 A NO 985341A NO 985341 L NO985341 L NO 985341L
Authority
NO
Norway
Prior art keywords
microparticles
inhalation
formulation
hfc
homogeneously
Prior art date
Application number
NO985341A
Other languages
English (en)
Other versions
NO985341D0 (no
Inventor
Ian Joseph Smith
Cheryl Vanessa Rogerson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of NO985341L publication Critical patent/NO985341L/no
Publication of NO985341D0 publication Critical patent/NO985341D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mikropartikler med en størrelse opp til 50 pm omfattende et terapeutisk middel og en surfaktant. De kan formuleres homogent med et HFC-drivstoff.
NO985341A 1996-05-17 1998-11-16 Formulering omfattende mikropartikler for inhalering NO985341D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9610341.1A GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation
PCT/GB1997/001309 WO1997044012A1 (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation

Publications (2)

Publication Number Publication Date
NO985341L true NO985341L (no) 1998-11-16
NO985341D0 NO985341D0 (no) 1998-11-16

Family

ID=10793869

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985341A NO985341D0 (no) 1996-05-17 1998-11-16 Formulering omfattende mikropartikler for inhalering

Country Status (9)

Country Link
JP (1) JP2000512268A (no)
KR (1) KR20000011020A (no)
AR (1) AR007178A1 (no)
AU (1) AU2783897A (no)
CA (1) CA2253478A1 (no)
GB (1) GB9610341D0 (no)
NO (1) NO985341D0 (no)
WO (1) WO1997044012A1 (no)
ZA (1) ZA974328B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
EP1767195A3 (en) * 1998-08-25 2007-04-04 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
AU758351B2 (en) * 1998-08-25 2003-03-20 Alkermes, Inc. Stable spray-dried protein formulations
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
CZ92497A3 (en) * 1994-09-29 1997-08-13 Andaris Ltd Micro-particles of water soluble material intended for use in therapy or diagnosis, inhaling apparatus containing such particles and application of a therapeutical agent

Also Published As

Publication number Publication date
JP2000512268A (ja) 2000-09-19
GB9610341D0 (en) 1996-07-24
CA2253478A1 (en) 1997-11-27
WO1997044012A1 (en) 1997-11-27
AR007178A1 (es) 1999-10-13
AU2783897A (en) 1997-12-09
ZA974328B (en) 1998-05-19
KR20000011020A (ko) 2000-02-25
NO985341D0 (no) 1998-11-16

Similar Documents

Publication Publication Date Title
NO985341L (no) Formulering omfattende mikropartikler for inhalering
DK0695172T3 (da) Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse
EE05210B1 (et) Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis
IL131626A0 (en) Water-soluble pharmaceutical composition in an ionic complex and the use thereof
AU3104301A (en) Compositions and methods to effect the release profile in the transdermal administration of active agents
AU3490300A (en) Dopamine agonists in combination with nitric oxide donors, compositions and methods of use
NZ332864A (en) Skin wash composition comprising an alpha-hydroxy, salicyclic, maleic or pyruvic acid
ES2153908T3 (es) Composiciones para revestimiento con propiedades antirreflectoras y antiempañamiento.
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
BR0107869A (pt) Composições farmacêuticas eletrogiradas
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
CA2054752A1 (en) Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
DK0758224T3 (da) Antitranspirantgelsammensætninger indbefattende chelateringsmidler
IL160109A0 (en) Topical pharmaceutical formulation
ATE68960T1 (de) Shampoo-praeparate.
EP0671658B8 (en) Exposure apparatus and reflection type mask to be used in the same
NZ239879A (en) Cleansing composition comprising two amphoteric surfactants-one being an imidazolinium derivative, the other an aminoalkanoate or iminodialkanoate, and an insoluble conditioning agent
ZA971892B (en) Compositions and use of benzamides and nicotin-amides as anti-inflammatory agents
ATE215810T1 (de) Abschuppungs-zusammensetzung
WO2002051535A3 (en) Preparation of microparticles having improved flowability
ATE287441T1 (de) Gefärbte teilchenzusammensetzung sowie diese enthaltende teilchenförmige waschmittel
FR2802222B1 (fr) Materiau composite absorbant, preparation et utilisation, notamment comme article d'essuyage industriel
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
NO985212D0 (no) Pulver vesikulµrt produkt
FI19992177L (fi) Seriiniproteaasi- ja paikallisesti käytettävä retinoidikoostumuksia